Skip to main content
. 2019 Oct 17;9(26):7981–8000. doi: 10.7150/thno.37568

Figure 3.

Figure 3

Schematic illustration of the BCPN for improved immunotherapy. (a) Self-assembly procedure of BCPN nanoparticles. (b) Schematic illustration of BCPN capable of modulating the immune response by eliciting antitumor immunity while suppressing regulatory T cells. Adapted with permission from 75, copyright 2018 John Wiley and Sons.